GR930100023A - Συνθεσεις αποσμητικου που περιεχουν υλικα για παρεμποδιση βακτηριακης προσκολλησης,μεθοδος χρησης αυτων και μεθοδος για προσδιορισμο υλικων που παρεμποδιζουν βακτηριακη προσκολληση. - Google Patents

Συνθεσεις αποσμητικου που περιεχουν υλικα για παρεμποδιση βακτηριακης προσκολλησης,μεθοδος χρησης αυτων και μεθοδος για προσδιορισμο υλικων που παρεμποδιζουν βακτηριακη προσκολληση.

Info

Publication number
GR930100023A
GR930100023A GR930100023A GR930100023A GR930100023A GR 930100023 A GR930100023 A GR 930100023A GR 930100023 A GR930100023 A GR 930100023A GR 930100023 A GR930100023 A GR 930100023A GR 930100023 A GR930100023 A GR 930100023A
Authority
GR
Greece
Prior art keywords
bacterial adherence
odor
materials
compositions containing
deodorant compositions
Prior art date
Application number
GR930100023A
Other languages
English (en)
Other versions
GR1002218B (en
Inventor
Edward Balish
Lawrence Morton Barr
Lucatelli Elaine Vanderhoof
Joseph Paul Vincenti
Mary Christine Vojt
Original Assignee
Mennen Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mennen Co filed Critical Mennen Co
Publication of GR930100023A publication Critical patent/GR930100023A/el
Publication of GR1002218B publication Critical patent/GR1002218B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00—Disinfection, sterilisation or deodorisation of air
    • A61L9/01—Deodorant compositions
    • A61L9/012—Deodorant compositions characterised by being in a special form, e.g. gels, emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/733—Alginic acid; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/737—Galactomannans, e.g. guar; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Dispersion Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Αποκαλύπτονται συνθέσεις αποσμητικού, συμπεριλαμβανομένων τωνσυνθέσεων αποσμητικού για μασχαλιαίες περιοχές και λοσιόνσώματος (π.χ. λοσιόν για μωρά), που μπορεί να μειώνουν τηνκακοσμία του σώματος (όπως κακοσμία που εμφανίζεται σεμασχαλιαίες περιοχές του ανθρώπινου σώματος) χωρίς χρήσηαντιμικροβιακών παραγόντων. Οι συνθέσεις περιλαμβάνουν έναυλικό (π.χ. που επιλέγεται από ειδικές γλυκοπρωτεϊνες καιυδατάνθρακες) που αναστέλλει προσκόλληση βακτηριδίωνπληθυσμοί που προκαλούν κακοσμία και η κακοσμία πουπροκαλείται από τέτοιους πληθυσμούς μειώνονται. Επίσηςαποκαλύπτεται αναλυτική τεχνική, χρησιμοποιώνταςδιαφοροποιημένα ανθρώπινα επιθηλιακά κύτταρα, που μπορεί ναχρησιμοποιείται για να προσδιορίζεται η ικανότηταεξεταζομένων υλικών να αναστέλλουν προσκόληση βακτηριδίων πουπροκαλούν κακοσμία σε επιφάνειες ανθρώπινου δέρματος.ω
GR930100023A 1992-01-22 1993-01-21 Deodorant compositions containing materials for inhibiting bacterial adherence, method of use thereof, and method for determining materials that inhibit bacterial adherence. GR1002218B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82377792A 1992-01-22 1992-01-22

Publications (2)

Publication Number Publication Date
GR930100023A true GR930100023A (el) 1993-09-30
GR1002218B GR1002218B (en) 1996-04-17

Family

ID=25239683

Family Applications (1)

Application Number Title Priority Date Filing Date
GR930100023A GR1002218B (en) 1992-01-22 1993-01-21 Deodorant compositions containing materials for inhibiting bacterial adherence, method of use thereof, and method for determining materials that inhibit bacterial adherence.

Country Status (13)

Country Link
EP (1) EP0561489A3 (el)
KR (1) KR930016107A (el)
CN (1) CN1080844A (el)
AU (1) AU671969B2 (el)
BR (1) BR9300245A (el)
CA (1) CA2087587A1 (el)
GR (1) GR1002218B (el)
HU (1) HUT65399A (el)
IL (1) IL104399A0 (el)
PL (1) PL297493A1 (el)
PT (1) PT101179A (el)
RO (1) RO112240B1 (el)
ZA (1) ZA93349B (el)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19503423A1 (de) * 1995-02-03 1996-08-08 Beiersdorf Ag Antiadhäsive Wirkstoffe
US5798094A (en) * 1996-09-24 1998-08-25 The Gillette Company Clear cosmetic stick composition with alkali chelate
EP1108056A1 (en) * 1998-08-28 2001-06-20 Colgate-Palmolive Company Method for testing anti-bacterial attachment compositions
US5951965A (en) * 1998-08-28 1999-09-14 Colgate Palmolive Company Method for visually demonstrating the effectiveness of an anti-bacteria attachment composition
US6425757B1 (en) * 2001-06-13 2002-07-30 Abb Lummus Global Inc. Pyrolysis heater with paired burner zoned firing system
US6719965B2 (en) * 2002-02-19 2004-04-13 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Antiperspirant or deodorant composition
US7332179B2 (en) 2003-12-12 2008-02-19 Kimberly-Clark Worldwide, Inc. Tissue products comprising a cleansing composition
PL2105122T3 (pl) * 2003-12-16 2013-03-29 Colgate Palmolive Co Kompozycja do higieny jamy ustnej i higieny osobistej i sposoby
US7642395B2 (en) 2004-12-28 2010-01-05 Kimberly-Clark Worldwide, Inc. Composition and wipe for reducing viscosity of viscoelastic bodily fluids
FR2883750B1 (fr) * 2005-04-04 2009-07-31 Virbac Sa Sa Compositions topiques et leurs utilisations
GB2447067A (en) * 2007-02-20 2008-09-03 Branko R Babic Alteration of osmotic gradients by polyhydroxy compounds
US20110200545A1 (en) * 2010-02-14 2011-08-18 Nyangenya Maniga Deodorant composition and methods for use thereof
FR2967905B1 (fr) * 2010-11-25 2013-07-12 Oreal Procede de traitement de la transpiration utilisant un compose carbonyle susceptible de reagir selon la reaction de maillard
FR2989274B1 (fr) * 2012-04-12 2016-02-26 Biochimie Appliquee Soc Composition cosmetique cutanee et/ou dermatologique destinee a limiter l'adhesion des bacteries pathogenes au niveau de la peau
FR3015248B1 (fr) * 2013-12-20 2016-12-09 Oreal Compositions cosmetiques deodorantes et/ou anti-transpirantes a base de lectine
FR3076216B1 (fr) * 2017-12-29 2022-09-23 Oreal Utilisation de derives de fucose comme agents deodorants
CN109794134A (zh) * 2019-03-18 2019-05-24 中山爱居环保科技有限公司 一种耐高温光催化持续释放型除醛净味膏体及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2401489A1 (de) * 1974-01-12 1975-07-24 Valentin Dr Med Koehler Deodorierende mittel
US4382919A (en) * 1980-09-15 1983-05-10 Bristol-Myers Company Composition for treatment and prevention of malodorous generating skin conditions
US4518517A (en) * 1983-03-16 1985-05-21 Colgate-Palmolive Company Non-antimicrobial deodorant cleansing composition
SU1359300A1 (ru) * 1986-01-27 1987-12-15 Научно-исследовательский институт экспериментальной медицины Способ определени антиинфекционной активности биологически активного соединени
CA2019051A1 (en) * 1989-07-26 1991-01-26 Morton L. Barr Deodorant compositions containing materials for inhibiting bacterial adherence, methods of use thereof, and method for determining materials that inhibit bacterial adherence

Also Published As

Publication number Publication date
RO112240B1 (ro) 1997-07-30
CA2087587A1 (en) 1993-07-23
BR9300245A (pt) 1993-09-28
GR1002218B (en) 1996-04-17
HUT65399A (en) 1994-06-28
AU3194493A (en) 1993-07-29
KR930016107A (ko) 1993-08-26
PT101179A (pt) 1994-02-28
HU9300167D0 (en) 1993-04-28
AU671969B2 (en) 1996-09-19
EP0561489A3 (en) 1993-10-27
PL297493A1 (el) 1993-10-04
EP0561489A2 (en) 1993-09-22
ZA93349B (en) 1995-10-19
CN1080844A (zh) 1994-01-19
IL104399A0 (en) 1993-05-13

Similar Documents

Publication Publication Date Title
GR930100023A (el) Συνθεσεις αποσμητικου που περιεχουν υλικα για παρεμποδιση βακτηριακης προσκολλησης,μεθοδος χρησης αυτων και μεθοδος για προσδιορισμο υλικων που παρεμποδιζουν βακτηριακη προσκολληση.
ATE155811T1 (de) Menschliche cyclooxygenase-2cdna und bestimmung von menschliche cyclooxygenase-2-inhibierung
DK0723774T3 (da) Anvendelse af en antagonist for CGRP i en kosmetisk, farmaceutisk eller dermatologisk sammensætning og den opnåede sammensæ
BR0106967A (pt) Dispositivo de acondicionamento e/ou de aplicação que contém fibras que possuem pelo menos um corpo imantado ou imantável
DE60239552D1 (de) Messung der protein-syntheseraten bei menschen und in experimentellen systemen durch verwendung von isotopisch markiertem wasser
DE69332721D1 (de) Dynamisches hochpräzisions-on-line-unterschriftprüfungssystem
ES2188759T3 (es) Derivados de la dolastatina, su preparacion y su uso.
FR2745173B1 (fr) Composition cosmetique de fixation et de brillance en aerosol et procedes
FR2745174B1 (fr) Composition cosmetique de fixation et de brillance
ATE250625T1 (de) IM WESENTLICHEN REINES ZONULIN ALS PHYSIOLOGISCHER MODULATOR VON ßTIGHT JUNCTIONSß BEI SÄUGERN
ITRM920688A0 (it) Apparecchio per l'analisi topografica di superfici anatomiche, in particolare della cornea
DE60218922D1 (de) Verfahren zur Erhöhung der Schwellentoleranz bei empfindlicher Haut
ES2076005T3 (es) Composicion cosmetica.
SE8700467D0 (sv) Cross-protective human monoclonal antibody compositions
BR9406223A (pt) Método para determinar em uma amostra a atividade funcional de um componente da coagulação sanguinea método para diagnosticar um disturbio da coagulação/anticoagulação sanguinea preparado de anticorpo linhagem celular uso de fator v subunidades ou fragmentos do mesmo tendo atividade anticoagulante na forma de cofator par apc prepraro de plasma embalado plasma deficiente em atividade anticoagulante de fator v como cofator para apc uso do preparado de anticorpo preparado de proteina s preparado de
DE69013972T2 (de) Kosmetische Zusammensetzung.
DE68908764T2 (de) Pufferlösungssysteme und Elektrolyten zur Eichung von Analysegeräten.
Bergler et al. Feasibility of proliferation studies using the BrdU and MTT assays with a head and neck carcinoma cell line
DE69324891D1 (de) Detektor zur Detektion von Ereignissen in lebendem Gewebe
Fitzgerald et al. Role of interferon in natural kill of herpesvirus infected fibroblasts
ES2013665A6 (es) Procedimiento para preparar un anticuerpo monoclonal humano y metodo de uso.
DE59208855D1 (de) Verwendung von Aminoalkyl-substituierten 5,6-Dihydro-dibenz(b,e)azepin-6,11-dion-11-oximen als antivirale Mittel
IT1254061B (it) Test immunoenzimatico per la ricerca e determinazione degli anticorpi anti-ss-dna.
FR2663748B1 (fr) Anticorps specifiques de la liaison isopeptidique induite par les transglutaminases, antigenes constitues par des isopeptides glu-lys reconnus par lesdits anticorps, agents de diagnostic et compositions therapeutiques les contenant.
ES1031743Y (es) Dispositivo para la medida y calculo del peso y volumen de objetos paralelepipedicos.